Thymomas are tumors of the thymus and are benign in around 75% of cases. A quarter of thymomas are malignant – they are divided into malignant thymomas and thymic carcinomas depending on the appearance and degree of differentiation of the diseased cells and their tendency to spread [1,3,4]. At 0.2-1.5% of all human malignancies in German-speaking countries and 1.7/1,000,000 in Europe, they account for a very small proportion.
Autoren
- Dr. med. Hans-Joachim Thiel
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- MASLD often goes unnoticed and is underestimated
Think tank for improving the supply situation
- DGPPN Congress
People at the center of care
- Lung cancer
Multidisciplinary teams in oncology
- Diagnostics of respiratory viral infections
What is tested when and on whom?
- Seborrheic dermatitis in adults
Do not underestimate the symptom burden
- SGLT2 inhibitors
Clear, simple language improves patient safety
- Moderate to severe atopic dermatitis
Established and novel biologics – the therapeutic landscape is in flux
- Recognize CKD early and avoid dialysis